Melody A Cobleigh, MD

Rush University Medical Center Division ...Chicago, Illinois - 60612 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS1
- SINCE2007

Phase II Open-Label Trial of Tarceva in Women With Metastatic Hormone- and HER2-Negative Breast Cancer
April 2007 - April 2011
Breast Neoplasms
Erlotinib



